416 related articles for article (PubMed ID: 21817944)
1. Management strategy of vestibular schwannoma in neurofibromatosis type 2.
Odat HA; Piccirillo E; Sequino G; Taibah A; Sanna M
Otol Neurotol; 2011 Sep; 32(7):1163-70. PubMed ID: 21817944
[TBL] [Abstract][Full Text] [Related]
2. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
[TBL] [Abstract][Full Text] [Related]
3. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
[TBL] [Abstract][Full Text] [Related]
4. Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up.
Neff BA; Wiet RM; Lasak JM; Cohen NL; Pillsbury HC; Ramsden RT; Welling DB
Laryngoscope; 2007 Jun; 117(6):1069-72. PubMed ID: 17545869
[TBL] [Abstract][Full Text] [Related]
5. Nerve of origin, tumor size, hearing preservation, and facial nerve outcomes in 359 vestibular schwannoma resections at a tertiary care academic center.
Jacob A; Robinson LL; Bortman JS; Yu L; Dodson EE; Welling DB
Laryngoscope; 2007 Dec; 117(12):2087-92. PubMed ID: 17921903
[TBL] [Abstract][Full Text] [Related]
6. Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2.
Nowak A; Dziedzic T; Czernicki T; Kunert P; Morawski K; Niemczyk K; Marchel A
Neurol Neurochir Pol; 2015; 49(5):295-301. PubMed ID: 26377980
[TBL] [Abstract][Full Text] [Related]
7. Outcome from surgery for vestibular schwannomas in children.
MacNally SP; Rutherford SA; King AT; Freeman S; Thorne J; Mawman D; O'Driscoll MP; Evans DG; Ramsden RT
Br J Neurosurg; 2009 Jun; 23(3):226-31. PubMed ID: 19533454
[TBL] [Abstract][Full Text] [Related]
8. Hearing preservation with the middle cranial fossa approach for neurofibromatosis type 2.
Friedman RA; Goddard JC; Wilkinson EP; Schwartz MS; Slattery WH; Fayad JN; Brackmann DE
Otol Neurotol; 2011 Dec; 32(9):1530-7. PubMed ID: 21986931
[TBL] [Abstract][Full Text] [Related]
9. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
Carlson ML; Breen JT; Driscoll CL; Link MJ; Neff BA; Gifford RH; Beatty CW
Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
[TBL] [Abstract][Full Text] [Related]
10. Hearing preservation in neurofibromatosis type 2.
Slattery WH; Brackmann DE; Hitselberger W
Am J Otol; 1998 Sep; 19(5):638-43. PubMed ID: 9752973
[TBL] [Abstract][Full Text] [Related]
11. Hearing preservation and facial nerve outcomes in vestibular schwannoma surgery: results using the middle cranial fossa approach.
Arts HA; Telian SA; El-Kashlan H; Thompson BG
Otol Neurotol; 2006 Feb; 27(2):234-41. PubMed ID: 16436995
[TBL] [Abstract][Full Text] [Related]
12. Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2.
Samii M; Matthies C; Tatagiba M
Neurosurgery; 1997 Apr; 40(4):696-705; discussion 705-6. PubMed ID: 9092842
[TBL] [Abstract][Full Text] [Related]
13. Hearing preservation surgery for neurofibromatosis Type 2-related vestibular schwannoma in pediatric patients.
Slattery WH; Fisher LM; Hitselberger W; Friedman RA; Brackmann DE
J Neurosurg; 2007 Apr; 106(4 Suppl):255-60. PubMed ID: 17465357
[TBL] [Abstract][Full Text] [Related]
14. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
[TBL] [Abstract][Full Text] [Related]
15. Auditory brainstem implant in neurofibromatosis type 2 and non-neurofibromatosis type 2 patients.
Grayeli AB; Kalamarides M; Bouccara D; Ambert-Dahan E; Sterkers O
Otol Neurotol; 2008 Dec; 29(8):1140-6. PubMed ID: 18849886
[TBL] [Abstract][Full Text] [Related]
16. Auditory brainstem implants in NF2 patients: results and review of the literature.
Sanna M; Di Lella F; Guida M; Merkus P
Otol Neurotol; 2012 Feb; 33(2):154-64. PubMed ID: 22246383
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation.
Zhao F; Wang B; Yang Z; Zhou Q; Li P; Wang X; Zhang J; Zhang J; Liu P
J Neurooncol; 2018 Jun; 138(2):417-424. PubMed ID: 29492767
[TBL] [Abstract][Full Text] [Related]
18. Facial nerve function and hearing preservation after retrosigmoid excision of vestibular schwannoma: Christchurch Hospital experience with 97 patients.
Darwish BS; Bird PA; Goodisson DW; Bonkowski JA; MacFarlane MR
ANZ J Surg; 2005 Oct; 75(10):893-6. PubMed ID: 16176235
[TBL] [Abstract][Full Text] [Related]
19. Outcome of translabyrinthine surgery for vestibular schwannoma in neurofibromatosis type 2.
Moffat DA; Lloyd SK; Macfarlane R; Mannion R; King A; Rutherford S; Axon PR; Donnelly N; Freeman S; Tysome JR; Evans DG; Ramsden RT
Br J Neurosurg; 2013 Aug; 27(4):446-53. PubMed ID: 23472624
[TBL] [Abstract][Full Text] [Related]
20. The retrosigmoid approach for auditory brainstem implantation.
Colletti V; Fiorino FG; Carner M; Giarbini N; Sacchetto L; Cumer G
Am J Otol; 2000 Nov; 21(6):826-36. PubMed ID: 11078071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
